Journals / Turkish Neurosurgery / 2019 / Cilt: 29 - Sayı: 4

The Evaluation of Killer Cell Immunoglobulin-Like Receptor Gene Polymorphism in Glioblastoma Patients

Pages
570–575
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, this clue may be a key factor in developing post-surgery individual immunotherapy models in the future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To assess the distribution of genetic polymorphisms of killer cell immunoglobulin-like receptors (KIRs) to predict the clinicalcourse of glioblastoma, report on the genetic mechanisms, and provide guidance on potential therapeutic methods.MATERIAL and METHODS: Our study included 31 adult patients who were admitted to the Department of Neurosurgery at ourinstitution and diagnosed with glioblastoma between October 2013 and January 2014 together with 50 control subjects.RESULTS: The mean age of the patients was 53.5 vs. 53.9 years, respectively, and the gender distribution (male/female: 64.5/35.5%vs. 64/36%, respectively) was comparable among patients and controls (p>0.05).
📊
Key Findings & Data:Sixteen different KIR genes including inhibitory,activating, and pseudogenes were investigated for each sample, and the framework genes including KIR2DL4, 3DL2, 3DL3, and3DP1 were present in all patients and controls.
💡
Conclusion & Impact:In addition, this clue may be a key factor in developing post-surgery individual immunotherapy models in the future.
🔬Design:Modeling & Simulation
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Özet

AIM: To assess the distribution of genetic polymorphisms of killer cell immunoglobulin-like receptors (KIRs) to predict the clinicalcourse of glioblastoma, report on the genetic mechanisms, and provide guidance on potential therapeutic methods.MATERIAL and METHODS: Our study included 31 adult patients who were admitted to the Department of Neurosurgery at ourinstitution and diagnosed with glioblastoma between October 2013 and January 2014 together with 50 control subjects.RESULTS: The mean age of the patients was 53.5 vs. 53.9 years, respectively, and the gender distribution (male/female: 64.5/35.5%vs. 64/36%, respectively) was comparable among patients and controls (p>0.05). Sixteen different KIR genes including inhibitory,activating, and pseudogenes were investigated for each sample, and the framework genes including KIR2DL4, 3DL2, 3DL3, and3DP1 were present in all patients and controls. In addition, the inhibitory KIR genes and the 2DL3 gene were significantly morecommon in patients compared to controls (p<0.05).CONCLUSION: This study demonstrated that the inhibitory KIR gene 2DL3 has a predisposition for glioblastoma. Identifying thepotential link between glioblastoma cells and immune system genetics is critical in predicting familial predisposition and earlydiagnosis. In addition, this clue may be a key factor in developing post-surgery individual immunotherapy models in the future.

🔖

Cite This Article

SARAC, M. E., OKTAY, K., OLGUNER, S. K., OZTURK, O. G., GOCER, A. I. (2019). The Evaluation of Killer Cell Immunoglobulin-Like Receptor Gene Polymorphism in Glioblastoma Patients. Turkish Neurosurgery, Cilt: 29 - Sayı: 4, 570–575. https://ajindex.com/articles/405309

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Al Omar S, Middleton D, Marshall E, Porter D, Xinarianos G, Raji O, Field JK, Christmas SE: Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. Hum Immunol 71(10):976-981, 2010 2. Auffinger B, Thaci B, Nigam P, Rincon E, Cheng Y, Lesniak MS: New therapeutic approaches for malignant glioma: In search of the Rosetta stone. F1000 Med Rep 4:18, 2012 3. Bahler DW, Hartung L, Hill S, Bowen GM, Vonderheid EC: CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sezary syndrome by flow cytometry. Cytometry B Clin Cytom 74(3):156-162, 2008 4. Besson C, Roetynck S, Williams F, Orsi L, Amiel C, Lependeven C, Antoni G, Hermine O, Brice P, Ferme C, Carde P, Canioni D, Brière J, Raphael M, Nicolas JC, Clavel J, Middleton D, Vivier E, Abel L: Association of killer cell immunoglobulin-like receptor genes with Hodgkin’s lymphoma in a familial study. PLoS One 2(5):e406, 2007 5. Broniscer A, Tatevossian RG, Sabin ND, Klimo P Jr, Dalton J, Lee R, Gajjar A, Ellison DW: Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma. Neuropathol Appl Neurobiol 40(3):327-336, 2014 6. Butsch Kovacic M, Martin M, Gao X, Fuksenko T, Chen CJ, Cheng YJ, Chen JY, Apple R, Hildesheim A, Carrington M: Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2673-2677, 2005 7. Chow D, Chang P, Weinberg BD, Bota DA, Grinband J, Filippi CG: Imaging genetic heterogeneity in glioblastoma and other glial tumors: Review of current methods and future directions. AJR Am J Roentgenol 210(1):30-38, 2018 8. Denis L, Sivula J, Gourraud PA, Kerdudou N, Chout R, Ricard C, Moisan JP, Gagne K, Partanen J, Bignon JD: Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 66(4):267-276, 2005 9. Gonzalez-Galarza FF, Takeshita LY, Santos EJ, Kempson F, Maia MH, da Silva AL, Teles e Silva AL, Ghattaoraya GS, Alfirevic A, Jones AR, Middleton D: Allele frequency net 2015 update: New features for HLA epitopesi KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res 43:D784-788, 2015 10. Kleinschmidt-DeMasters BK, Aisner DL, Birks DK, Foreman NK: Epithelioid GBMs show a high percentage of BRAF V600E mutation. Am J Surg Pathol 37(5):685-698, 2013 11. Kleinschmidt-DeMasters BK, Alassiri AH, Bi